voriconazole
UkraineDrugs containing this active substance
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by species of Candida, Scedosporium, and Fusarium. It is also used for the prevention of fungal infections in patients following stem cell transplantation.
Form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Aspiron Pharma Limited
-
The drug is used for the prevention of invasive fungal infections during allogeneic bone marrow transplantation, as well as for the treatment of invasive aspergillosis, candidemia, and severe infections caused by Candida species (including those resistant to fluconazole), Scedosporium, and Fusarium.
Form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Yuria-Pharm LLC, Ukraine (packaging of bulk products from manufacturer Anfarm Hellas S.A., Greece)
-
The drug is used to treat invasive aspergillosis, candidemia, as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging, quality control of batch)
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of fungal infections in patients following bone marrow transplantation.
Form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Hainan Poly Pharma Co., Ltd.
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by species of Candida, Scedosporium, and Fusarium. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: lyophilisate for concentrate for infusion solution
Active substance Dosage voriconazole 200 mg ATC: J02AC03
-
It is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Candida, Scedosporium, and Fusarium species. The drug is also prescribed for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Farmaten S.A. (secondary packaging, batch control, responsible for batch release)
-
The drug is used to treat invasive aspergillosis, candidemia (a blood infection caused by Candida fungi), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of fungal infections in patients following bone marrow transplantation.
Form: tablets, film-coated
Active substance Dosage voriconazole 50 mg ATC: J02AC03
Manufacturer: Farmaten S.A. (primary and secondary packaging, batch control, responsible for batch release)
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), severe fungal infections caused by Scedosporium and Fusarium species, as well as for the prevention of fungal infections in patients after bone marrow transplantation.
Form: tablets, film-coated
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Farmaten S.A. (primary and secondary packaging, batch control, responsible for batch release)
-
The drug is used to treat invasive aspergillosis, candidemia, as well as severe fungal infections caused by Candida species (including those resistant to fluconazole), Scedosporium, and Fusarium. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: tablets, film-coated
Active substance Dosage voriconazole 50 mg ATC: J02AC03
Manufacturer: Synthon Hispania, S.L. (batch release)
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Candida, Scedosporium, and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: tablets, film-coated
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Synthon Hispania, S.L. (batch release)
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of fungal infections in patients following bone marrow transplantation.
Form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: ANFARM HELLAS S.A. (manufacturing of finished dosage form, primary and secondary packaging, batch control, batch release)
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Candida, Scedosporium, and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: tablets, film-coated
Active substance Dosage voriconazole 200 mg ATC: J02AC03
Manufacturer: Evertoxgen Life Sciences Limited
-
The drug is used to treat invasive aspergillosis, candidemia (blood infection), as well as severe fungal infections caused by Scedosporium and Fusarium species. It is also used for the prevention of invasive fungal infections in patients following bone marrow transplantation.
Form: tablets, film-coated
Active substance Dosage voriconazole 50 mg ATC: J02AC03
Manufacturer: Evertoxgen Life Sciences Limited